Company presentations are the cornerstone of the annual J.P. Morgan Healthcare Conference, but one of the most well-attended talks at this year's meeting was delivered by Kimberly Powell, vice president and general manager of health care at NVIDIA. Given that what happens at JPM is a reliable indicator of things to come, this year is set to be the year big tech takes a prominent seat at the biopharma table.
Powell made two industry-related announcements. First, she said AI-driven drug biotech Recursion Pharmaceuticals, Inc., into which NVIDIA has invested...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?